BACKGROUND AND AIMS: Percutaneous nephrolithotomy (PCNL) is a safe and effective endourologic procedure in patients with renal calculi. Though it is less painful than open surgery, effective postoperative analgesia is required to reduce the pain around the nephrostomy site. Objectives of this study are to compare and evaluate the peritubal infiltration of bupivacaine, ropivacaine, and placebo from renal capsule to skin along the nephrostomy tract for postoperative analgesia in percutaneous nephrolithotomy (PCNL). MATERIALS AND METHODS: A randomized controlled double blinded study was designed in 60 American Society of Anesthesiologists (ASA) grade I and II patients to assess & compare the impact of peritubal infiltration of bupivacaine, ropivacaine, saline with 23-gauge spinal needle along the nephrostomy tract after PCNL under fluoroscopic guidance. Patients were randomized into 3 groups B (bupivacaine), R (ropivacaine), S (saline/control). Each group containing 20 patients were given 20mL of respective drug at the conclusion of the procedure. Postoperative pain score and analgesic requirement for the first 24 hours were assessed by visual analog scale second hourly. Rescue analgesia with inj. Tramadol 2mg/kg was given intravenously to a maximum total dose of 400mg when pain score exceeded 4. RESULTS: Pain scores and analgesic requirement for the first 24 hours postoperatively were lesser in the B (bupivacaine) & R(ropivacaine) groups than in the S(saline/control) group of patients at all points of time and were statistically significant (p<0.005). CONCLUSION: In this study a significant difference in the pain scores and analgesic requirement was noted in saline and drug groups. Peritubal infiltration of 0.25% bupivacaine or 0.375% ropivacaine solutions is equally efficient in alleviating postoperative pain after PCNL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.